Nanotechnology Now - News Story: "MIDAS Research Initiates Coverage of Biophan Technologies"

Home > News > MIDAS Research Initiates Coverage of Biophan Technologies

August 10th, 2005

MIDAS Research Initiates Coverage of Biophan Technologies

Abstract:
MIDAS Research has published a research report on the nano-medical technology company Biophan
Technologies, Inc. (OTC BB: BIPH, Frankfurt: BTN) with a 12 month target price per share of USD 4.20 and a buy recommendation.

Source:
prnewswire

Bookmark:

Related Links

Biophan Technologies

Related News Press

Investments/IPO's/Splits

QWave Fund Powers Physics and Materials Science-Based Innovation With Initial Round of Venture Capital Investments: New VC Fund Invests Total of $7M in Nano-Meta Technologies, Centice and Clifton June 19th, 2013

Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013

Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013

Harris & Harris Group Notes Carl Zeiss' Planned Acquisition of Xradia June 13th, 2013

Announcements

Less is More: Novel Cellulose Structure Requires Fewer Enzymes to Process Biomass to Fuel June 19th, 2013

Sound waves precisely position nanowires June 19th, 2013

Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013

Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013

Financial Reports

Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013

Harris & Harris Group Reports Financial Statements as of March 31, 2013 May 10th, 2013

Arrowhead Reports Fiscal 2013 Second Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time May 9th, 2013

Arrowhead to Report Fiscal 2013 Second Quarter Financial Results - Conference Call Scheduled for Thursday, May 9, 2013 May 2nd, 2013